Vitasora Health Limited (ASX:VHL)
Australia
· Delayed Price · Currency is AUD 0.0380
-0.0020 (-5.00%)
At close: May 23, 2025, 4:00 PM AEST
Vitasora Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 1.24 | 0.46 | 0.07 | 0.25 | 0.27 | - | Upgrade
|
| Other Revenue | 0.61 | 0.58 | 0.59 | 0.52 | 1.12 | 2.16 | Upgrade
|
| Revenue | 1.85 | 1.04 | 0.66 | 0.77 | 1.39 | 2.16 | Upgrade
|
| Revenue Growth (YoY) | 133.47% | 56.85% | -14.26% | -44.29% | -35.69% | 110.02% | Upgrade
|
| Cost of Revenue | 0.3 | 0 | 0.07 | 0.26 | 1.26 | - | Upgrade
|
| Gross Profit | 1.55 | 1.03 | 0.6 | 0.51 | 0.12 | 2.16 | Upgrade
|
| Selling, General & Admin | 8.51 | 7.36 | 5.57 | 5.29 | 7.22 | 4.15 | Upgrade
|
| Research & Development | 0.17 | 0.14 | 0.38 | 1.46 | 1.39 | 2.04 | Upgrade
|
| Operating Expenses | 9.13 | 8.1 | 6.36 | 7.14 | 11.21 | 9.47 | Upgrade
|
| Operating Income | -7.58 | -7.06 | -5.76 | -6.63 | -11.09 | -7.31 | Upgrade
|
| Interest Expense | -0 | -0.07 | -0.02 | - | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | 0.01 | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.05 | 0.05 | Upgrade
|
| Pretax Income | -7.58 | -7.13 | -5.78 | -6.62 | -11.04 | -7.26 | Upgrade
|
| Net Income | -7.58 | -7.13 | -5.78 | -6.62 | -11.04 | -7.26 | Upgrade
|
| Net Income to Common | -7.58 | -7.13 | -5.78 | -6.62 | -11.04 | -7.26 | Upgrade
|
| Shares Outstanding (Basic) | 1,171 | 1,018 | 806 | 729 | 699 | 570 | Upgrade
|
| Shares Outstanding (Diluted) | 1,171 | 1,018 | 806 | 729 | 699 | 570 | Upgrade
|
| Shares Change (YoY) | 34.76% | 26.19% | 10.68% | 4.23% | 22.63% | 14.21% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | Upgrade
|
| Free Cash Flow | -7.5 | -6.64 | -4.51 | -8.48 | -7.39 | -4.7 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 83.63% | 99.63% | 90.09% | 66.42% | 8.84% | 100.00% | Upgrade
|
| Operating Margin | -408.89% | -680.22% | -870.00% | -858.74% | -800.27% | -339.28% | Upgrade
|
| Profit Margin | -408.98% | -686.48% | -872.26% | -857.85% | -796.57% | -336.89% | Upgrade
|
| Free Cash Flow Margin | -404.78% | -639.50% | -681.46% | -1098.15% | -533.43% | -218.10% | Upgrade
|
| EBITDA | -7.62 | -7.05 | -5.75 | -6.62 | -11.08 | -7.31 | Upgrade
|
| D&A For EBITDA | -0.04 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EBIT | -7.58 | -7.06 | -5.76 | -6.63 | -11.09 | -7.31 | Upgrade
|
| Revenue as Reported | 1.85 | 1.04 | 0.66 | 0.78 | 1.44 | 2.21 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.